Latest action: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Bill requires transparency about genetic and molecular testing in healthcare.
The problem
Patients and doctors lack clear information about how genetic and molecular tests work, what they cost, and how companies use genetic data.
The proposal
Bill mandates companies disclose test methods, accuracy rates, pricing, and data usage practices to patients and healthcare providers.
The impact
Patients gain clearer test information. Testing companies must increase transparency. Healthcare providers make better informed decisions about which tests to order.
People will understand what genetic tests can and cannot do. They'll know costs upfront and how their genetic information might be used. This helps patients make informed decisions about their health.
Physicians will have standardized information about test accuracy and reliability. This reduces unnecessary testing and improves diagnosis quality. Better information leads to better patient outcomes.
Transparency requirements clarify how companies handle genetic information. Patients know who accesses their data and for what purposes. This strengthens privacy protections for sensitive biological information.
When pricing and quality are transparent, patients can compare testing options. Companies must compete on fairness and accuracy. Competition can drive down costs and improve services.
Testing companies must develop new systems to track and report data. Smaller companies might struggle with these expenses. These costs could be passed to patients through higher prices.
More disclosure means longer, more detailed information for patients to review. Some people may find technical testing details confusing. Too much information can overwhelm rather than help.
Defining exact transparency requirements and enforcement takes time. Agencies must develop guidelines and monitor compliance. Rules might be difficult to standardize across different test types.
Detailed disclosure of test methods might reveal proprietary company information. Competitors could potentially copy successful approaches. This could reduce company incentive to innovate in genetic testing.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.